Matthew Kulke, MD
Specialty: Medical Oncology
Boston Medical Center, Boston University School of Medicine
Multidisciplinary NET treatment program
830 Harrison Ave 3rd floor
Boston, Massachusetts
Patient scheduling: (617) 638-7524
90%
of practice is NET patients
20
years’ experience treating NETs
150
published NET-related research papers
Matthew Kulke, MD is actively involved in neuroendocrine cancer research.
Research interests:
Development of new therapeutic strategies and treament options for NETs
Subspecialty areas:
- Lung NETs
- GI NETs
- Pancreatic NETs
- Pheochromocytoma/Paraganglioma
- Liver metastasis
- Nuclear medicine
NET-related professional association memberships:
- North American Neuroendocrine Tumor Society (NANETS)
- European Neuroendocrine Tumor Society (ENETS)
- American Association of Cancer Research (AACR)
- American Society of Clinical Oncology
Leadership role(s):
- North American Neuroendocrine Tumor Society (NANETS)
Educational presentations by Matthew Kulke, MD
- Overview pancreatic neuroendocrine tumors, Bay Area Patient Conference 2017
NETRF-funded research projects
NETRF has awarded Matthew Kulke, MD, research grants for the following projects: